Abstract:Development of dry powder aerosol delivery system involves powder production, formulation, dispersion, delivery, and deposition of the powder aerosol in the airways. Insufficiency of conventional powder production by crystallization and milling has led to development of alternative techniques. Over the last decade, performance of powder formulations has been improved significantly through the use of engineered drug particles and excipient systems which are (i) of low aerodynamic diameters (being porous or of low particle density), and/or (ii) less cohesive and adhesive (via corrugated surfaces, low bulk density, reduced surface energy and particle interaction, hydrophobic additives, and fine carrier particles). Early insights into particle forces and surface energy that help explain the improvement have been provided by analytical techniques such as the atomic force microscopy (AFM) and inverse gas chromatography (IGC). Relative humidity is critical to the performance of dry powder inhaler (DPI) products via capillary force and electrostatic interaction. Electrostatic charge of different particle size fractions of an aerosol can now be measured using a modified electrical low-pressure impactor (ELPI). Compared with powders, much less work has been done on the inhaler devices at the fundamental level. Most recently, computational fluid dynamics has been applied to understand how the inhaler design (such as mouthpiece, grid structure, air inlet) affects powder dispersion. The USP throat is known to under-represent the oropharyngeal deposition of DPI aerosols. Studies using magnetic resonance imaging (MRI) model casts have been undertaken to explain the inter- and intra- subject variation in oropharyngeal deposition. Most of the lung deposition studies performed on commercial products did not allow a thorough understanding of the determinants affecting in vivo lung deposition. A more systematic approach would be necessary to build a useful database on the dependence of lung deposition on the breathing parameters, inhaler design, and powder formulation properties.

Combining experimental and computational techniques to understand and improve dry powder inhalers

Recent developments in the computational simulation of dry powder inhalers

Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies

Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications

In-vitro and Particle Image Velocimetry Studies of Dry Powder Inhalers

Engineering the right formulation for enhanced drug delivery

Dry Powder Aerosol Delivery Systems: Current and Future Research Directions

Design, development, and technical considerations for dry powder inhaler devices

Dry powder inhalation, part 2: the present and future

Discrete Modelling of Powder Dispersion in Dry Powder Inhalers - A Brief Review.

Numerical study of effects of device design on drug delivery efficiency for an active dry powder inhaler

Progress on Dry Powder Inhalers

Understanding the role of swirling flow in dry powder inhalers implications for design considerations and pulmonary delivery

Evaluating dry powder inhalers: From in vitro studies to mobile health technologies

Surface Analytical Techniques in Solid-State Particle Characterization for Predicting Performance in Dry Powder Inhalers

On the Use of Computational Fluid Dynamics (CFD) Modelling to Design Improved Dry Powder Inhalers

3D Characterisation of Dry Powder Inhaler Formulations: Developing X-ray Micro Computed Tomography Approaches.

Dry Powder Inhalers: From Bench to Bedside

A Real-Time and Modular Approach for Quick Detection and Mechanism Exploration of DPIs with Different Carrier Particle Sizes

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers

Formulation and Evaluation of Dry Powder Inhaler